Invention Application
US20130040975A1 GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO
有权
促性腺激素释放激素受体拮抗剂及其相关方法
- Patent Title: GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO
- Patent Title (中): 促性腺激素释放激素受体拮抗剂及其相关方法
-
Application No.: US13572510Application Date: 2012-08-10
-
Publication No.: US20130040975A1Publication Date: 2013-02-14
- Inventor: Graham Beaton , Mi Chen , Timothy Richard Coon , Todd Ewing , Wanlong Jiang , Jinghua Yu , Willy Moree , Warren Wade , Liren Zhao , Yun-fei Zhu , Martin Rowbottom , Neil Ashweek
- Applicant: Graham Beaton , Mi Chen , Timothy Richard Coon , Todd Ewing , Wanlong Jiang , Jinghua Yu , Willy Moree , Warren Wade , Liren Zhao , Yun-fei Zhu , Martin Rowbottom , Neil Ashweek
- Applicant Address: US CA San Diego
- Assignee: NEUROCRINE BIOSCIENCES, INC.
- Current Assignee: NEUROCRINE BIOSCIENCES, INC.
- Current Assignee Address: US CA San Diego
- Main IPC: C07D213/61
- IPC: C07D213/61 ; C07D239/36 ; A61K31/513 ; C07D213/84 ; A61K31/444 ; C07D405/12 ; A61K31/443 ; C07C311/15 ; C07D215/14 ; C07D495/04 ; A61P5/24 ; A61P15/00 ; A61P17/00 ; A61P35/00 ; A61P13/08 ; A61P15/08 ; A61K31/4418

Abstract:
GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure: wherein R1a, R1b, R1c, R1d, R2, R2a, and A are as defined herein, including stereoisomers, esters, solvates, and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.
Public/Granted literature
- US08507536B2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Public/Granted day:2013-08-13
Information query